Search
for
Sort by
Research 601–630 of 1000+
- Diagnosing Vascular Causes of Renal Failure
- Liver Cirrhosis and Circadian Rhythm
- Investigation Bisphenol A and Phthalate Levels in Idiopathic Hyperandrogenemia
- Reticulocyte hemoglobin content as a best indicator of iron deficiency in female patients with diffuse non-scarring hair loss
- Nonsurgical Therapy for Hair Loss
- Microneedling in Dermatology: A Review
- Search Advances in Lip Skin Biology and Anti-Aging Strategies
- Androgen treatment in women
- Alterations in androgen conjugate levels in women and men with alopecia
- Fractional microneedle radiofrequency for photoaging and atrophic acne scar: a split-face clinical observation of two devices
- 1407 ANDROGENETIC ALOPECIA, PROSTATE VOLUME AND URINARY SYMPTOMS. IS THERE A RELATIONSHIP? A CASE-CONTROL STUDY
- Assessment of the Effects of Facial Hair Removal Laser on Thyroid Hormones
- Alopecia Areata: A tissue specific autoimmune disease of the hair follicle
- The pathogenesis of alopecia areata
- Is dehydroepiandrosterone a hormone?
- Advances of Non-Ionic Surfactant Vesicles (Niosomes) and Their Application in Drug Delivery
- Dermatoses of pregnancy
- The pharmacology of methotrexate
- An Update of Congenital Adrenal Hyperplasia
- Topical minoxidil in early male pattern baldness
- Extracellular Matrix Degradation Products and Low-Oxygen Conditions Enhance the Regenerative Potential of Perivascular Stem Cells
- Olfactory receptor OR2AT4 regulates human hair growth
- Electrospun Nanofibers for Improved Angiogenesis: Promises for Tissue Engineering Applications
- Recent advances in microneedle composites for biomedical applications: Advanced drug delivery technologies
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Effects of epidermal growth factor, fibroblast growth factor, minoxidil and hydrocortisone on growth kinetics in human hair bulb papilla cells and root sheath fibroblasts cultured in vitro
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Nonclassic adrenal hyperplasia
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- Prolactin: an emerging force along the cutaneous–endocrine axis